Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of CRLX101 (Formerly Named IT-101) in the Treatment of Advanced Solid Tumors
This study has been completed.
Study NCT00333502   Information provided by Cerulean Pharma Inc.

First Received on June 1, 2006.   Last Updated on July 30, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Sponsors listed in this trial